Preview

Epilepsy and paroxysmal conditions

Advanced search

THE ROLE OF THE THERAPEUTIC DRUG MONITORING WHEN USING ANTIEPILEPTIC DRUGS

https://doi.org/10.17749/2077-8333.2016.8.3.066-073

About the Authors

A. V. Yakunina
Samara State Medical University
Russian Federation

Yakunina Albina Viktorovna – PhD, Assoc. Prof. of the Department  of neurology and neurosurgery.

Ul. Chapaevskaya, 89, Samara, Russia, 443099. Tel. +7(846)9561684.  E-mail: ayakunina@bk.ru



I. E. Poverennova
Samara State Medical University
Russian Federation

Poverennova Irina Evgenievna – MD, D. Med. Sci., Prof., head of the Department of neurology and neurosurgery.

Ul. Chapaevskaya, 89, Samara, Russia, 443099. Tel. +7(846)9561684,  E-mail: samaranevr@mail.ru



References

1. Abaimov D. A., Sariev A. К., Noskova T. Y., Shvedkov V. V., Shirayeva M. V., Stirova E. Y., Prohorov D. I., Seifulla R. D. Epilepsiya i paroksizmal’nye sostoyaniya / Epilepsy and paroxysmal conditions. 2013; 2: 31-41.

2. Aivazyan S. O. Epilepsiya i paroksizmal’nye sostoyaniya / Epilepsy and paroxysmal conditions. 2010; 3: 28-33.

3. Andreeva O. V. Klinicheskaya farmakokinetika. 2005; 1: 29-33.

4. Belousov Y. B., Leonova M. V., Shteinberg L. L., Tishenkova I. F., Sokolov A. V. Epilepsiya i paroksizmal’nye sostoyaniya / Epilepsy and paroxysmal conditions. 2013; 3: 6-16.

5. Instruction for medical application of a medicinal preparation of a keppa. http://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=4434519f-78a9-4235-8911-0c38941a34df&t=. Accessed: 08.07.2016.

6. Leonova M. V., Belousov Y. B., Tishenkova I. F., Shteinberg L. L., Sokolov A. V. Epilepsiya i paroksizmal’nye sostoyaniya / Epilepsy and paroxysmal conditions. 2014; 4: 6-14.

7. Noskova T. Y. Annaly Klinicheskoy i Eksperimental’noy Nevrologii/Annals of clinical and experimental neurology. 2009; 3: 37-40.

8. Prokudin M. Y. Therapeutic drug monitoring of antiepileptic drugs: clinicpharmacological justification. Abstract of the candidate of medical sciences. SPb 2007, 27 p.

9. Schnayder N. A., Dmitrenko D. V., Govorina Y. B., Muraveva A. V., Kotlovsky J. V.,Bochanova E.N., Fateeva E. A., Dedyuk N. A., Mustafayeva A. V. Farmakogenetika i farmakogenomika/ Pharmacogenetics and pharmacogenomics. 2015; 2: 24-28.

10. Ghodke-Puranik Y., Thorn C. F., Lamba J. K. et al. Valproic acid pathway: pharmacokinetics and pharmacodynamics. Pharmacogenetics and genomics. 2013; 23 (4): 236-41.

11. Neels H. M., Sierens A. C., Naelaerts K. et al. Therapeutic drug monitoring of old and newer antiepileptic drugs. Clin. Chem. Lab. Med. 2004; 42 (11): 1228-55.

12. Patsalos P. N., Berry D. J., Bourgeois B. F. et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008; 49 (7): 1239-76.

13. Warner A., Privitera M., David B. Аntiepileptic drug monitoring. Clinical Chemistry. 1998; 44 (5): 1085-95.


Review

For citations:


Yakunina A.V., Poverennova I.E. THE ROLE OF THE THERAPEUTIC DRUG MONITORING WHEN USING ANTIEPILEPTIC DRUGS. Epilepsy and paroxysmal conditions. 2016;8(3):66-73. (In Russ.) https://doi.org/10.17749/2077-8333.2016.8.3.066-073

Views: 1067


ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)